What are the recommended eye drops for allergic conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Eye Drops for Allergic Conjunctivitis

Dual-action agents (antihistamine + mast cell stabilizer) such as olopatadine, ketotifen, epinastine, and azelastine are the most effective first-line treatment for allergic conjunctivitis due to their rapid onset of action and ability to both treat acute symptoms and prevent future episodes. 1, 2

First-Line Treatment Options

  • Dual-action agents have an onset of action within 30 minutes and are suitable for both acute and longer-term treatment of allergic conjunctivitis 1, 2
  • Olopatadine: Apply 1 drop in the affected eye(s) twice daily, every 6-8 hours, for adults and children 2 years and older 3
  • Ketotifen: Apply 1 drop in the affected eye(s) twice daily, every 8-12 hours, for adults and children 3 years and older 4
  • Cold compresses and irrigation with saline solution or artificial tears are recommended for mild symptoms 1, 2
  • Refrigerated preservative-free artificial tears can provide additional relief by diluting allergens and inflammatory mediators 2, 5

Second-Line Treatment Options

  • Mast cell stabilizers (cromolyn sodium, lodoxamide, nedocromil, pemirolast) are better for prophylactic or longer-term treatment due to their slow onset of action (several days) 1, 2
  • Cromolyn sodium: Apply 1-2 drops in each eye 4-6 times daily at regular intervals 6
  • Topical NSAIDs, such as ketorolac, are indicated for temporary relief of ocular itching caused by seasonal allergic conjunctivitis 7, 2
  • Antihistamines (emedastine, levocabastine) are effective for acute relief but may not have the preventive benefits of dual-action agents 7, 2

Third-Line Treatment Options

  • For severe cases or acute exacerbations, a brief course (1-2 weeks) of topical corticosteroids with a low side effect profile, such as loteprednol etabonate, may be added to the regimen 1, 5
  • Monitoring for increased IOP, cataract formation, and secondary infections is necessary when using topical corticosteroids 2, 5
  • For vernal keratoconjunctivitis or atopic conjunctivitis, topical cyclosporine 0.05% has been shown to be effective 1

Comparative Efficacy

  • In comparative studies, olopatadine was preferred by patients over ketotifen for both efficacy and comfort 8
  • Epinastine, ketotifen, and olopatadine have shown efficacy comparable to fluorometholone in clinical trials 9
  • All topical antihistamines and mast cell stabilizers appear to reduce symptoms and signs of allergic conjunctivitis compared to placebo in the short term 10

Important Considerations and Precautions

  • Prolonged use of ocular vasoconstrictors can lead to rebound hyperemia (conjunctivitis medicamentosa) 7, 2
  • Oral antihistamines may worsen dry eye syndrome and impair the tear film's protective barrier 2, 5
  • Many ophthalmic medications contain preservatives that may contribute to ocular surface damage in patients with comorbid dry eye disease 11
  • Avoid punctal plugs in allergic conjunctivitis as they prevent flushing of allergens and inflammatory mediators 5
  • When using multiple ophthalmic products, wait at least 5 minutes between applications 3

Special Populations

  • For children under 2-3 years (depending on the medication), consult a doctor before using 4, 3
  • For severe or refractory cases, consultation with an allergist or ophthalmologist may be beneficial 1, 5

References

Guideline

Allergic Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Allergic Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Options for Allergic Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Allergic Conjunctivitis Management: Update on Ophthalmic Solutions.

Current allergy and asthma reports, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.